Standout Papers

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity H... 2010 2026 2015 2020 1.4k
  1. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial (2010)
    Murray Esler, Henry Krum et al. The Lancet
  2. Update on Myocarditis (2012)
    Ingrid Kindermann, Christine Barth et al. Journal of the American College of Cardiology
  3. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study (2013)
    Henry Krum, Markus P. Schlaich et al. The Lancet
  4. Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension (2011)
    Felix Mahfoud, Markus P. Schlaich et al. Circulation
  5. Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension (2012)
    Mathias C. Brandt, Felix Mahfoud et al. Journal of the American College of Cardiology
  6. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022)
    Felix Mahfoud, David E. Kandzari et al. The Lancet
  7. Sex differences in arterial hypertension (2022)
    Eva Gerdts, Isabella Sudano et al. European Heart Journal
  8. Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation (2025)
    Tobias Reichlin, Thomas Kueffer et al. New England Journal of Medicine

Immediate Impact

2 from Science/Nature 67 standout
Sub-graph 1 of 16

Citing Papers

Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice
2024 Standout
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction
2024 Standout

Works of Felix Mahfoud being referenced

Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
2022
Update on Myocarditis
2012 Standout

Author Peers

Author Last Decade Papers Cites
Felix Mahfoud 11289 2460 1888 486 13.2k
Kazuyuki Shimada 8900 2644 1314 331 12.0k
Vasilios Papademetriou 6968 1781 2437 294 10.1k
George S. Stergiou 11087 3585 1310 374 14.8k
Renata Cífková 7627 1749 2444 209 11.9k
Satoshi Hoshide 7844 1904 968 367 10.2k
Charalambos Vlachopoulos 11894 2487 2683 298 17.1k
Paolo Verdecchia 12254 2666 2414 313 16.3k
Abraham A. Kroon 4487 1775 1301 269 8.8k
Anthony M. Heagerty 10202 2952 2972 278 15.5k
Eoin OʼBrien 15435 6880 3990 261 20.7k

All Works

Loading papers...

Rankless by CCL
2026